An advanced wound care company has acquired a diabetic foot ulcer treatment firm in a $14.5 million deal. The acquisition reflects Derma Sciences’ strategy to acquire higher-margined companies with ...

Diabetes, a condition that affects how our bodies use sugar, can lead to various complications. It can damage the nerves and blood vessels enough to cause wounds in the feet. Left untreated, these ...

For more than two decades, Saint Peter’s University Hospital has been a leader in the comprehensive, evidence-based advanced treatment of chronic, non-healing wounds. Wound Care Center® and Hyperbaric ...

Study published in the peer-reviewed journal, 'International Wound Journal' POMPANO BEACH, Fla., Oct. 17, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company ...

Pune, India, May 25, 2021 (GLOBE NEWSWIRE) -- The global “diabetic foot ulcer treatment market” size is projected to showcase remarkable growth on account of the increasing prevalence of diabetes ...

The Centers for Disease Control and Prevention reports that there are 30.3 million people living with diabetes in the United States. Diabetes comes with many serious complications, including chronic ...

The proportion of wounds healed at 16 weeks was higher with intact fish skin grafts than with standard-of-care (44.0% vs 26.4% adjusted odds ratio [aOR], 2.58; 95% CI, 1.48-4.56). The fish skin grafts ...

Please provide your email address to receive an email when new articles are posted on . Adults with high transepidermal water loss at the closure of a diabetic foot ulcer wound had greater odds for ...

Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "India Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report by Treatment (Wound Care Dressings, Biologics, Therapy Devices, ...

Artificial intelligence is increasingly transforming wound care, particularly in managing complex cases such as diabetic foot ulcers. By integrating advanced imaging techniques with deep learning, ...

POMPANO BEACH, Fla., Oct. 17, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of ...